Structure-function analysis of human protein O-linked mannose β1,2-N-acetylglucosaminyltransferase 1, POMGnT1

被引:33
作者
Akasaka-Manya, K
Manya, H
Kobayashi, K
Toda, T
Endo, T
机构
[1] Tokyo Metropolitan Inst Gerontol, Glycobiol Res Grp, Fdn Res Aging & Promot Human Welf, Itabashi Ku, Tokyo 1730015, Japan
[2] Osaka Univ, Grad Sch Med, Div Funct Genom, Dept Post Genom & Dis, Osaka 5650871, Japan
关键词
muscle-eye-brain disease; muscular dystrophy; glycosyltransferase; catalytic domain; stem domain; mutation; POMGnT1;
D O I
10.1016/j.bbrc.2004.05.129
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) catalyzes the transfer of GlcNAc to O-mannose of glycoproteins. Mutations in the POMGnT1 gene cause a type of congenital muscular dystrophy called muscle-eye-brain disease (MEB). We evaluated several truncated mutants of PoMGnT1 to determine the minimal catalytic domain. Deletions of 298 amino acids in the N-terminus and 9 amino acids in the C-terminus did not affect POMGnT1 activity, while larger deletions on either end abolished activity. These data indicate that the minimal catalytic domain is at least 353 amino acids. Single amino acid substitutions in the stem domain of POMGnT1 from MEB patients abolished the activity of the membrane-bound form but not the soluble form. This suggests that the stem domain of the soluble form of POMGnT1 is unnecessary for activity, but that some amino acids play a crucial role in the membrane-bound form. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:39 / 44
页数:6
相关论文
共 25 条
[1]  
Chiba A, 1997, J BIOL CHEM, V272, P2156
[2]   Glycosylation in congenital muscular dystrophies [J].
Endo, T ;
Toda, T .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2003, 26 (12) :1641-1647
[3]   O-mannosyl glycans in mammals [J].
Endo, T .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1999, 1473 (01) :237-246
[4]   DEFINING THE MINIMAL SIZE OF CATALYTICALLY ACTIVE PRIMATE ALPHA-1,3 GALACTOSYLTRANSFERASE - STRUCTURE-FUNCTION STUDIES ON THE RECOMBINANT TRUNCATED ENZYME [J].
HENION, TR ;
MACHER, BA ;
ANARAKI, F ;
GALILI, U .
GLYCOBIOLOGY, 1994, 4 (02) :193-201
[5]   Deficiency of α-dystroglycan in muscle-eye-brain disease [J].
Kano, H ;
Kobayashi, K ;
Herrmann, R ;
Tachikawa, M ;
Manya, H ;
Nishino, I ;
Nonaka, I ;
Straub, V ;
Talim, B ;
Voit, T ;
Topaloglu, H ;
Endo, T ;
Yoshikawa, H ;
Toda, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 291 (05) :1283-1286
[6]   Comparison of glycosyltransferase families using the profile hidden Markov model [J].
Kikuchi, N ;
Kwon, YD ;
Gotoh, M ;
Narimatsu, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 310 (02) :574-579
[7]   Characterization of α2,6-sialyltransferase cleavage by Alzheimer's β-secretase (BACE1) [J].
Kitazume, S ;
Tachida, Y ;
Oka, R ;
Kotani, N ;
Ogawa, K ;
Suzuki, M ;
Dohmae, N ;
Takio, K ;
Saido, TC ;
Hashimoto, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (17) :14865-14871
[8]   Alzheimer's β-secretase, β-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase [J].
Kitazume, S ;
Tachida, Y ;
Oka, R ;
Shirotani, K ;
Saido, TC ;
Hashimoto, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13554-13559
[9]   Minimal catalytic domain of N-acetylglucosaminyltransferase V [J].
Korczak, B ;
Le, T ;
Elowe, S ;
Datti, A ;
Dennis, JW .
GLYCOBIOLOGY, 2000, 10 (06) :595-599
[10]   Loss-of-function of an N-acetylglucosaminyltransferase, POMGnT1, in muscle-eye-brain disease [J].
Manya, H ;
Sakai, K ;
Kobayashi, K ;
Taniguchi, K ;
Kawakita, M ;
Toda, T ;
Endo, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 306 (01) :93-97